James S. Scibetta - 15 Jun 2021 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role
Director
Signature
/s/ Lori Braender, as Attorney-In-Fact
Issuer symbol
AQST
Transactions as of
15 Jun 2021
Net transactions value
$0
Form type
4
Filing time
17 Jun 2021, 18:51:00 UTC
Next filing
24 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AQST Common Stock 31,635 15 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AQST Stock Option (Right to Purchase) Award $0 +20,000 $0.000000 20,000 15 Jun 2021 Common Stock 20,000 $4.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the options vest as follows: 100% of the underlying shares vest June 15, 2022, subject to Mr. Scibetta's continuous service with the Issuer from the grant date through the applicable vesting date.